Probably everything is on such an old stack due to the regulatory pipeline of getting the software approved. I suspect that if this stack is as major a change as the authors suggest, that it will be at least five years before it could be used given the impact of getting something wrong - https://en.wikipedia.org/wiki/Therac-25
Although FDA regulations are important, for in-house software inside the clinics, we could use them with the approval of IRB (internal review board). A lot of software developed in the clinics are actually being used for treating patients.
Seems to me we can continue to use the known-reliable tech stack, but put a nicer UI on it for explaining the treatment planning process, for simulations, etc.
Now, explain why you'd need GPU-accelerated dose calculation.
The one showing at default is not a real patient, it's a human phantom. You can load a real CT image with its RT Plan to see the real patient treatment data.
I’m not asking about your web page. I’m asking if this procedure is currently in use on patients and how that process currently works. I see no need to change the stack behind an approved treatment, and you haven’t made a case for moving it to the GPU.
If this treatment is not available to patients in the real world because realtime planning is required but the compute is unavailable, then maybe you have a point.
Now, explain why you'd need GPU-accelerated dose calculation.
If this treatment is not available to patients in the real world because realtime planning is required but the compute is unavailable, then maybe you have a point.